135 related articles for article (PubMed ID: 31765157)
1. Transnasal Delivery of the Peptide Agonist Specific to Neuromedin-U Receptor 2 to the Brain for the Treatment of Obesity.
Tanaka A; Takayama K; Furubayashi T; Mori K; Takemura Y; Amano M; Maeda C; Inoue D; Kimura S; Kiriyama A; Katsumi H; Miyazato M; Kangawa K; Sakane T; Hayashi Y; Yamamoto A
Mol Pharm; 2020 Jan; 17(1):32-39. PubMed ID: 31765157
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models.
Sampson CM; Kasper JM; Felsing DE; Raval SR; Ye N; Wang P; Patrikeev I; Rytting E; Zhou J; Allen JA; Hommel JD
Pharmacol Res Perspect; 2018 Oct; 6(5):e00425. PubMed ID: 30151213
[TBL] [Abstract][Full Text] [Related]
3. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.
Takayama K; Mori K; Asari T; Sohma Y; Nomura E; Sasaki Y; Taguchi A; Taniguchi A; Miyazato M; Minamino N; Kangawa K; Hayashi Y
Bioorg Med Chem Lett; 2020 Sep; 30(18):127436. PubMed ID: 32721452
[TBL] [Abstract][Full Text] [Related]
5. A chemically stable peptide agonist to neuromedin U receptor type 2.
Takayama K; Mori K; Tanaka A; Sasaki Y; Sohma Y; Taguchi A; Taniguchi A; Sakane T; Yamamoto A; Miyazato M; Minamino N; Kangawa K; Hayashi Y
Bioorg Med Chem; 2020 May; 28(10):115454. PubMed ID: 32247748
[TBL] [Abstract][Full Text] [Related]
6. Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.
Kanematsu-Yamaki Y; Nishizawa N; Kaisho T; Nagai H; Mochida T; Asakawa T; Inooka H; Dote K; Fujita H; Matsumiya K; Hirabayashi H; Sakamoto J; Ohtaki T; Takekawa S; Asami T
J Med Chem; 2017 Jul; 60(14):6089-6097. PubMed ID: 28657315
[TBL] [Abstract][Full Text] [Related]
7. Amide-to-chloroalkene substitution for overcoming intramolecular acyl transfer challenges in hexapeptidic neuromedin U receptor 2 agonists.
Narumi T; Toyama D; Fujimoto J; Kyan R; Sato K; Mori K; Pearson JT; Mase N; Takayama K
Chem Commun (Camb); 2024 Mar; 60(26):3563-3566. PubMed ID: 38465405
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.
Takayama K; Mori K; Tanaka A; Nomura E; Sohma Y; Mori M; Taguchi A; Taniguchi A; Sakane T; Yamamoto A; Minamino N; Miyazato M; Kangawa K; Hayashi Y
J Med Chem; 2017 Jun; 60(12):5228-5234. PubMed ID: 28548497
[TBL] [Abstract][Full Text] [Related]
9. [Medicinal Chemistry Focused on Mid-sized Peptides Derived from Biomolecules].
Takayama K
Yakugaku Zasshi; 2019; 139(11):1377-1384. PubMed ID: 31685733
[TBL] [Abstract][Full Text] [Related]
10. Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration.
Hatakawa Y; Tanaka A; Furubayashi T; Nakamura R; Konishi M; Akizawa T; Sakane T
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683967
[TBL] [Abstract][Full Text] [Related]
11. Suppressive Effects of Neuromedin U Receptor 2-Selective Peptide Agonists on Appetite and Prolactin Secretion in Mice.
Nomoto A; Suzuki Y; Morito K; Nagasawa K; Takayama K
ACS Med Chem Lett; 2024 Mar; 15(3):376-380. PubMed ID: 38505846
[TBL] [Abstract][Full Text] [Related]
12. Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application.
Tanaka A; Furubayashi T; Arai M; Inoue D; Kimura S; Kiriyama A; Kusamori K; Katsumi H; Yutani R; Sakane T; Yamamoto A
Mol Pharm; 2018 Mar; 15(3):1105-1111. PubMed ID: 29338251
[TBL] [Abstract][Full Text] [Related]
13. PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.
Ingallinella P; Peier AM; Pocai A; Marco AD; Desai K; Zytko K; Qian Y; Du X; Cellucci A; Monteagudo E; Laufer R; Bianchi E; Marsh DJ; Pessi A
Bioorg Med Chem; 2012 Aug; 20(15):4751-9. PubMed ID: 22771182
[TBL] [Abstract][Full Text] [Related]
14. Pharmacomodulation of brain neuromedin U signaling as a potential therapeutic strategy.
Pałasz A; Worthington JJ; Filipczyk Ł; Saganiak K
J Neurosci Res; 2023 Nov; 101(11):1728-1736. PubMed ID: 37496289
[TBL] [Abstract][Full Text] [Related]
15. Transnasal delivery of 5-fluorouracil to the brain in the rat.
Sakane T; Yamashita S; Yata N; Sezaki H
J Drug Target; 1999; 7(3):233-40. PubMed ID: 10680979
[TBL] [Abstract][Full Text] [Related]
16. Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy.
Shingaki T; Inoue D; Furubayashi T; Sakane T; Katsumi H; Yamamoto A; Yamashita S
Mol Pharm; 2010 Oct; 7(5):1561-8. PubMed ID: 20695463
[TBL] [Abstract][Full Text] [Related]
17. Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide.
Neuner P; Peier AM; Talamo F; Ingallinella P; Lahm A; Barbato G; Di Marco A; Desai K; Zytko K; Qian Y; Du X; Ricci D; Monteagudo E; Laufer R; Pocai A; Bianchi E; Marsh DJ; Pessi A
J Pept Sci; 2014 Jan; 20(1):7-19. PubMed ID: 24222478
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
Shi S; Wu J; Dai W; Li C; Ge W
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
[TBL] [Abstract][Full Text] [Related]
19. The transnasal delivery of 5-fluorouracil to the rat brain is enhanced by acetazolamide (the inhibitor of the secretion of cerebrospinal fluid).
Shingaki T; Hidalgo IJ; Furubayashi T; Katsumi H; Sakane T; Yamamoto A; Yamashita S
Int J Pharm; 2009 Jul; 377(1-2):85-91. PubMed ID: 19446619
[TBL] [Abstract][Full Text] [Related]
20. Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2.
Takayama K; Mori K; Taketa K; Taguchi A; Yakushiji F; Minamino N; Miyazato M; Kangawa K; Hayashi Y
J Med Chem; 2014 Aug; 57(15):6583-93. PubMed ID: 24999562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
